Diabetes in pregnancy
NICE guidelines, January 2016 http://www.nice.org.uk/guidance/QS109
Leggi
Giallo
Le Breaking News di colore giallo sono relative a notizie dalle agenzie regolatorie o da società scientifiche: nuovi farmaci, ritiri, eventi avversi rilevanti…
AIFA – Gestione del diabete in gravidanza: nuovo standard di qualità del NICE
27/01/2016 http://www.agenziafarmaco.gov.it/it/content/gestione-del-diabete-gravidanza-nuovo-standard-di-qualit%C3%A0-del-nice
Leggi
EMA – Metformin and metformin-containing medicines – Review of metformin-containing medicines started
01/02/2016 http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Metoformin_and_ metformin-containing_medicines/human_referral_000397.jsp&mid=WC0b01ac05805c516f
Leggi
FDA approves Integra Omnigraft Dermal Regeneration Matrix to treat diabetic foot ulcers.
January 7, 2016 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm480564.htm
Leggi
Standards of Medical Care in Diabetes – 2016
Diabetes Care 2016;39:S4-S5 http://care.diabetesjournals.org/content/39/Supplement_1
Leggi
FDA Drug Safety Communication: FDA eliminates the Risk Evaluation and Mitigation Strategy (REMS) for rosiglitazone-containing diabetes medicines
16712/2015
FDA Drug Safety Communication: FDA eliminates the Risk Evaluation and Mitigation Strategy (REMS) for rosiglitazone-containing diabetes medicines
Leggi
FDA approves Basaglar, the first “follow-on” insulin glargine product to treat diabetes
16/12/2015
FDA approves Basaglar, the first “follow-on” insulin glargine product to treat diabetes
Leggi
NICE GUIDANCE – Diabetes mellitus type 1 and type 2: insulin glargine biosimilar (Abasaglar)
Dicembre 2015
NICE GUIDANCE – Diabetes mellitus type 1 and type 2: insulin glargine biosimilar (Abasaglar)
Leggi
NICE GUIDANCE – Type 2 diabetes mellitus in adults: high-strength insulin glargine 300 units-ml (Toujeo)
December 2015 http://www.nice.org.uk/advice/esnm65/resources/type-2-diabetes-mellitus-in-adults-highstrength-insulin-glargine-300-unitsml-toujeo-1502681106901957
Leggi
AIFA – Registro di Monitoraggio online del medicinale EYLEA
02/11/2015
AIFA informa che a partire dal 21/10/2015 è presente sulla piattaforma web il Registro di Monitoraggio del medicinale EYLEA, indicato per il trattamento negli adulti di compromissione della vista dovuta a edema maculare diabetico (Diabetic Macular Oedema – DME)
Leggi